Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K _____________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39535 SHARECARE, INC. (Exact name of registrant as specified in its charter) De ...

And itÂ's also very tightly woven into Life Sciences. So we have a really unique asset in Life Sciences. And with cookies going away, this idea of a zero-party database where I have got 100 million people or I know their e-mail and they filled out 100 questions on RealAge. And they have given me permission to talk to them, itÂ's a huge asset, whether we are helping our payer partners, recruit members or our hospital partners, recruit patients or us using that -- their advanced targeting to get more members ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________ FORM 10-Q _____________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39535 SHARECARE, INC. (Ex ...

Sharecare, Inc. (NASDAQ:SHCR) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Jeff Arnold - Co-Founder, Chairman, Chief Executive Officer Justin Ferrero - Chief Financial Officer Jaffry Mohammed - Chief Operating Officer Conference Call Participants David Larsen - BTIG Richard Close - Canaccord Craig Hettenbach - Morgan Stanley Cindy Motz - Goldman Sachs Dolph Warburton - Nephron Research Operator Good day, everyone and welcome to the Sharecare Third Quarter 2022 Earnings ...

| --- | --- | --- | --- | --- | --- | --- | --- | |-----------|--------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | sharecare | | | | | | | | | better | All together | | | | | | | Important Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on belie ...

sharecare All together better Important Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: "outlook," "target," "reflect," "on track," "foresees," "tuture," "will," "shall," "could," "would," "expect", "intend" "plan," f ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________ FORM 10-Q _____________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39535 SHARECARE, INC. (Exact name ...

Sharecare, Inc. (NASDAQ:SHCR) Q2 2022 Earnings Conference Call August 10, 2022 8:00 AM ET Company Participants Evan Smith - Senior Vice President of Finance & Investor Relations Jeff Arnold - Chairman & Chief Executive Officer Justin Ferrero - President & Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley David Larsen - BTIG Eric Percher - Nephron Research Richard Close - Canaccord Genuity Cindy Motz - Goldman Sachs Operator Good day, and welcome to the Sharecare Second Q ...

| --- | --- | --- | --- | --- | --- | --- | |-----------|--------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | D | | | | | | | | sharecare | | | | | | | | better | All together | | | | | | Important Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. I ...

OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________ FORM 10-Q _____________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 (Address of Principal Executive Offices) (Zip Code) 3030 ...